- 全部删除
- 您的购物车当前为空
VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) 是一种通过血红素加氧酶(HO-1) 相关机制的选择性抗肿瘤剂;维生素 K3 类似物。
为众多的药物研发团队赋能,
让新药发现更简单!
VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) 是一种通过血红素加氧酶(HO-1) 相关机制的选择性抗肿瘤剂;维生素 K3 类似物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 313 | In stock | |
5 mg | ¥ 762 | In stock | |
10 mg | ¥ 1,130 | In stock | |
25 mg | ¥ 1,910 | In stock | |
50 mg | ¥ 2,730 | In stock | |
100 mg | ¥ 3,850 | In stock | |
200 mg | ¥ 5,270 | In stock |
产品描述 | VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) is a selective antitumor agent via heme oxygenase (HO-1) related mechanisms; Vitamine K3 analogue. |
别名 | 2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na |
分子量 | 262.32 |
分子式 | C14H14O3S |
CAS No. | 255906-59-3 |
Smiles | COCCSC1=C(C)C(=O)c2ccccc2C1=O |
密度 | 1.25 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 25 mg/mL (95.3 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容